BNO Share Price History
02 Jun, 2020
Bionomics A$20-A$22 million recapitalisation led by Apeiron Investment Group
31 Mar, 2020
Published preclinical findings for Bionomics Limited's BNC375 explore the potential of this novel molecule to improve cognitive impairment.
20 Mar, 2020
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We...
11 Dec, 2019
Bionomics Limited has accepted offer from Domain Therapeutics for subsidiaries Neurofit SAS and PC SAS (Prestwick Chemical) in France.
04 Nov, 2019
Bionomics Announces Fast Track Designation Granted by U.S. FDA to BNC210 Development Program for the Treatment of PTSD
Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a global, clinical stage biopharmaceutical company discovering and developing a pipeline of novel drug candidates targeting ion channels, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development program for the treatment of Post-Traumatic Stress Disorder (PTSD) and other trauma-related and stressor-related disorders.
23 Sep, 2019
If you own shares in Bionomics Limited (ASX:BNO) then it's worth thinking about how it contributes to the volatility...